RWA Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
2,343
-142
| -6% | -$63.2K | 0.01% | 323 |
|
|
2025
Q1 | $1.2M | Sell |
2,485
-1,098
| -31% | -$532K | 0.02% | 293 |
|
|
2024
Q4 | $1.44M | Buy |
3,583
+95
| +3% | +$38.3K | 0.02% | 278 |
|
|
2024
Q3 | $1.62M | Buy |
3,488
+65
| +2% | +$30.2K | 0.02% | 263 |
|
|
2024
Q2 | $1.6M | Hold |
3,423
| – | – | 0.02% | 253 |
|
|
2024
Q1 | $1.43M | Sell |
3,423
-195
| -5% | -$81.5K | 0.02% | 264 |
|
|
2023
Q4 | $1.47M | Buy |
3,618
+2,778
| +331% | +$1.13M | 0.02% | 253 |
|
|
2023
Q3 | $292K | Buy |
+840
| New | +$292K | 0.01% | 326 |
|
|
2018
Q3 | – | Sell |
-88
| Closed | -$15K | – | 686 |
|
|
2018
Q2 | $15K | Buy |
88
+35
| +66% | +$5.97K | ﹤0.01% | 570 |
|
|
2018
Q1 | $9K | Buy |
+53
| New | +$9K | ﹤0.01% | 459 |
|